staurosporine aglycone has been researched along with Idiopathic Parkinson Disease in 2 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Real, CC | 1 |
| Ferreira, AF | 1 |
| Chaves-Kirsten, GP | 1 |
| Torrão, AS | 1 |
| Pires, RS | 1 |
| Britto, LR | 1 |
| Wang, LH | 1 |
| Besirli, CG | 1 |
| Johnson, EM | 1 |
1 review available for staurosporine aglycone and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Mixed-lineage kinases: a target for the prevention of neurodegeneration.
Topics: Alzheimer Disease; Animals; Carbazoles; Hearing Loss; Humans; Indole Alkaloids; Indoles; JNK Mitogen | 2004 |
1 other study available for staurosporine aglycone and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
BDNF receptor blockade hinders the beneficial effects of exercise in a rat model of Parkinson's disease.
Topics: Analysis of Variance; Animals; Apomorphine; Carbazoles; Corpus Striatum; Disease Models, Animal; Enz | 2013 |